These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 16113469)

  • 1. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease.
    MacNee W
    Proc Am Thorac Soc; 2005; 2(1):50-60. PubMed ID: 16113469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidants/antioxidants and chronic obstructive pulmonary disease: pathogenesis to therapy.
    MacNee W
    Novartis Found Symp; 2001; 234():169-85; discussion 185-8. PubMed ID: 11199095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidants and COPD.
    MacNee W
    Curr Drug Targets Inflamm Allergy; 2005 Dec; 4(6):627-41. PubMed ID: 17305519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current perspectives of oxidative stress and its measurement in chronic obstructive pulmonary disease.
    Lin JL; Thomas PS
    COPD; 2010 Aug; 7(4):291-306. PubMed ID: 20673039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidants/antioxidants and COPD.
    MacNee W
    Chest; 2000 May; 117(5 Suppl 1):303S-17S. PubMed ID: 10843965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy.
    Kirkham P; Rahman I
    Pharmacol Ther; 2006 Aug; 111(2):476-94. PubMed ID: 16458359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease.
    Macnee W; Rahman I
    Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 2):S58-65. PubMed ID: 10556172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress in pathogenesis of chronic obstructive pulmonary disease: cellular and molecular mechanisms.
    Rahman I
    Cell Biochem Biophys; 2005; 43(1):167-88. PubMed ID: 16043892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cigarette smoke-induced oxidative stress: A role in chronic obstructive pulmonary disease skeletal muscle dysfunction.
    Barreiro E; Peinado VI; Galdiz JB; Ferrer E; Marin-Corral J; Sánchez F; Gea J; Barberà JA;
    Am J Respir Crit Care Med; 2010 Aug; 182(4):477-88. PubMed ID: 20413628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update in chronic obstructive pulmonary disease: role of antioxidant and metabolizing gene polymorphisms.
    Lakhdar R; Denden S; Kassab A; Leban N; Knani J; Lefranc G; Miled A; Chibani JB; Khelil AH
    Exp Lung Res; 2011 Aug; 37(6):364-75. PubMed ID: 21721950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of exhaled air condensate in assessing the oxidant-antioxidant system in patients with chronic obstructive pulmonary disease.
    Makarevich AE; Ivashkevich DL
    Wiad Lek; 2003; 56(1-2):19-23. PubMed ID: 12901263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease.
    Barreiro E; de la Puente B; Minguella J; Corominas JM; Serrano S; Hussain SN; Gea J
    Am J Respir Crit Care Med; 2005 May; 171(10):1116-24. PubMed ID: 15735057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COPD: balancing oxidants and antioxidants.
    Fischer BM; Voynow JA; Ghio AJ
    Int J Chron Obstruct Pulmon Dis; 2015; 10():261-76. PubMed ID: 25673984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of oxidants/antioxidants in smoking-induced lung diseases.
    Rahman I; MacNee W
    Free Radic Biol Med; 1996; 21(5):669-81. PubMed ID: 8891669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NRF2 targeting: a promising therapeutic strategy in chronic obstructive pulmonary disease.
    Boutten A; Goven D; Artaud-Macari E; Boczkowski J; Bonay M
    Trends Mol Med; 2011 Jul; 17(7):363-71. PubMed ID: 21459041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of chronic obstructive pulmonary disease.
    Macnee W
    Clin Chest Med; 2007 Sep; 28(3):479-513, v. PubMed ID: 17720039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of antioxidant enzymes and increased expression of chemokines in COPD lung.
    Tomaki M; Sugiura H; Koarai A; Komaki Y; Akita T; Matsumoto T; Nakanishi A; Ogawa H; Hattori T; Ichinose M
    Pulm Pharmacol Ther; 2007; 20(5):596-605. PubMed ID: 16919984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of inflammation during exacerbations of chronic obstructive pulmonary disease.
    Kersul AL; Iglesias A; Ríos Á; Noguera A; Forteza A; Serra E; Agustí A; Cosío BG
    Arch Bronconeumol; 2011 Apr; 47(4):176-83. PubMed ID: 21454005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidant--antioxidant imbalance in asthma: scientific evidence, epidemiological data and possible therapeutic options.
    Nadeem A; Masood A; Siddiqui N
    Ther Adv Respir Dis; 2008 Aug; 2(4):215-35. PubMed ID: 19124374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ROS in the local and systemic pathogenesis of COPD.
    Langen RC; Korn SH; Wouters EF
    Free Radic Biol Med; 2003 Aug; 35(3):226-35. PubMed ID: 12885585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.